Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 15 EU countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better.

From the week of April 6th, we are planning to work on 15 projects, including:

Reimbursement

  1. Working on reimbursement analysis for an in-vitro diagnostic test in the oncology area in France, Germany, Italy, and Spain
  2. Working on market access strategy for novel technology in organ transplantation in the Netherlands
  3. Working on reimbursement analysis for minimally invasive technology in vascular surgery in Denmark, England, France, Germany, Italy, Sweden, and Switzerland
  4. Working on reimbursement analysis for minimally invasive technologies in oncology and vascular surgery in England, Germany, and the Netherlands
  5. Working on reimbursement analysis for minimally invasive technology in the cardiovascular area in Germany
  6. Working on organizational and funding overview for the rare disease area in Denmark, England, Germany, and Sweden
  7. Working on reimbursement analysis for in-vitro diagnostic tests in the neurology area in England, France, Germany, Italy, and Spain
  8. Working on reimbursement analysis for diagnostic technology in the cardiology area in seven European countries

HEOR

  1. Working on the development of a health economic model for in-vitro diagnostic tests in neurology disease areas in England, France, Germany, Italy, and Spain 
  2. Working on the adaptation of a health economic model for an imaging diagnostic system in different European and Middle Eastern countries
  3. Working on the validation of a health economic model in the cardiology area
  4. Working on a systematic literature review and meta-analysis for an in vitro diagnostic test
  5. Working on the development of a health economic model for technology in the cardiovascular area in England
  6. Working on evidence gap analysis for minimally invasive technology in vascular surgery 
  7. Working on an update of a systematic literature review for a minimally invasive technology in the neurology area

Let us know if you need any market access or HEOR support for your medical technology in Europe